168 related articles for article (PubMed ID: 20063085)
1. [Testosterone and the metabolic syndrome].
Schubert M; Jockenhövel F
Urologe A; 2010 Jan; 49(1):47-50. PubMed ID: 20063085
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
Hackett G
Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
[TBL] [Abstract][Full Text] [Related]
3. MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.
Lapauw B; Kaufman JM
Eur J Endocrinol; 2020 Dec; 183(6):R167-R183. PubMed ID: 33105105
[TBL] [Abstract][Full Text] [Related]
4. Testosterone therapy has positive effects on anthropometric measures, metabolic syndrome components (obesity, lipid profile, Diabetes Mellitus control), blood indices, liver enzymes, and prostate health indicators in elderly hypogonadal men.
Canguven O; Talib RA; El Ansari W; Yassin DJ; Salman M; Al-Ansari A
Andrologia; 2017 Dec; 49(10):. PubMed ID: 28295504
[TBL] [Abstract][Full Text] [Related]
5. Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone.
Heufelder AE; Saad F; Bunck MC; Gooren L
J Androl; 2009; 30(6):726-33. PubMed ID: 19578132
[TBL] [Abstract][Full Text] [Related]
6. The role of testosterone in type 2 diabetes and metabolic syndrome in men.
Saad F
Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):901-7. PubMed ID: 20126841
[TBL] [Abstract][Full Text] [Related]
7. Testosterone in obesity, metabolic syndrome and type 2 diabetes.
Stanworth R; Jones T
Front Horm Res; 2009; 37():74-90. PubMed ID: 19011290
[TBL] [Abstract][Full Text] [Related]
8. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes.
Groti K; Žuran I; Antonič B; Foršnarič L; Pfeifer M
Aging Male; 2018 Sep; 21(3):158-169. PubMed ID: 29708829
[TBL] [Abstract][Full Text] [Related]
9. Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes.
Wang C; Jackson G; Jones TH; Matsumoto AM; Nehra A; Perelman MA; Swerdloff RS; Traish A; Zitzmann M; Cunningham G
Diabetes Care; 2011 Jul; 34(7):1669-75. PubMed ID: 21709300
[No Abstract] [Full Text] [Related]
10. Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome.
Jones TH
J Diabetes; 2010 Sep; 2(3):146-56. PubMed ID: 20923480
[TBL] [Abstract][Full Text] [Related]
11. Effect of clomiphene citrate treatment on the Sertoli cells of dysmetabolic obese men with low testosterone levels.
Pelusi C; Fanelli F; Baccini M; Triggiani V; Bartolomeo N; Carbone MD; De Pergola G; Di Dalmazi G; Pagotto U; Pasquali R; Giagulli VA
Clin Endocrinol (Oxf); 2020 Jan; 92(1):38-45. PubMed ID: 31677181
[TBL] [Abstract][Full Text] [Related]
12. Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials.
Grossmann M; Hoermann R; Wittert G; Yeap BB
Clin Endocrinol (Oxf); 2015 Sep; 83(3):344-51. PubMed ID: 25557752
[TBL] [Abstract][Full Text] [Related]
13. Testosterone and insulin resistance in the metabolic syndrome and T2DM in men.
Rao PM; Kelly DM; Jones TH
Nat Rev Endocrinol; 2013 Aug; 9(8):479-93. PubMed ID: 23797822
[TBL] [Abstract][Full Text] [Related]
14. Effects of testosterone replacement therapy on metabolic syndrome among Japanese hypogonadal men: A subanalysis of a prospective randomised controlled trial (EARTH study).
Shigehara K; Konaka H; Nohara T; Izumi K; Kitagawa Y; Kadono Y; Iwamoto T; Koh E; Mizokami A; Namiki M
Andrologia; 2018 Feb; 50(1):. PubMed ID: 28497534
[TBL] [Abstract][Full Text] [Related]
15. Obesity, low testosterone levels and erectile dysfunction.
Diaz-Arjonilla M; Schwarcz M; Swerdloff RS; Wang C
Int J Impot Res; 2009; 21(2):89-98. PubMed ID: 18843273
[TBL] [Abstract][Full Text] [Related]
16. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance.
Traish AM; Saad F; Guay A
J Androl; 2009; 30(1):23-32. PubMed ID: 18772488
[TBL] [Abstract][Full Text] [Related]
17. Testosterone, diabetes mellitus, and the metabolic syndrome.
Spark RF
Curr Urol Rep; 2007 Nov; 8(6):467-71. PubMed ID: 18042326
[TBL] [Abstract][Full Text] [Related]
18. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome.
Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S; Mohanty P
Curr Mol Med; 2008 Dec; 8(8):816-28. PubMed ID: 19075678
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-18 and testosterone levels in men with metabolic syndrome.
Angelova P; Kamenov Z; Tsakova A; El-Darawish Y; Okamura H
Aging Male; 2018 Jun; 21(2):130-137. PubMed ID: 29168426
[TBL] [Abstract][Full Text] [Related]
20. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
